CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-07-01 | Russell Angus C. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-07-01 | Russell Angus C. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-06-29 | Russell Angus C. Director | Option exercise | +24,720 | $2.20 | $54K | 92,220 |
| 2021-06-29 | Russell Angus C. Director | Sale | −4,720 | $2.97 | $14K | 87,500 |
| 2021-06-29 | Russell Angus C. Director | Option exercise · Stock Option (right to buy) | −24,720 | 0 | ||
| 2020-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-07-01 | Russell Angus C. Director | Grant or award · Option to Purchase Common Shares | +40,000 | 40,000 | ||
| 2017-07-01 | Russell Angus C. Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 |
Page 1 of 1 · 13 trades